PD-1 blocking treatment may convert TAMs from tumor-promoting to tumor-fighting, improving outcomes in metastatic clear cell kidney cancer. Higher levels of CD163-positive TAMs are linked to better ...

Our results provide mechanistic evidence that immune responses to EBV can directly damage the brain in MS,” said Olivia Thomas, PhD, assistant professor at the Department of Clinical Neuroscience at ...

At times, aging doesn’t become evident in wrinkles or in gray hair, it occurs deep inside your body, in cells that have ceased to divide but are still alive. These “zombie cells,” or senescent cells ...

Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

Hypothyroidism is a significant risk factor for IPF, with a higher prevalence in IPF patients compared to the general population. Mendelian randomization confirmed the association between ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms. Now, researchers from Japan ...

The gastrointestinal tract is the biggest immune organ in mammals. The gut extends its influence all over the body through various links like the gut-liver axis, the gut-lung axis, and the gut-brain ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...